Clinical Trials for Umoja Biopharma

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Umoja Biopharma

Clinical Trials (2)

A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies

PHASE1Recruiting

106 participants

Started: Mar 10, 2025 · Completed: Mar 31, 2029

4 conditions1 sponsor8 locations

A Phase I Feasibility And Safety Study of Fluorescein-Specific (FITC-E2) CAR T Cells In Combination With Parenterally Administered Folate-Fluorescein (UB-TT170) For Osteogenic Sarcoma

PHASE1Active, not recruiting

21 participants

Started: May 20, 2022 · Completed: May 31, 2040

1 condition2 sponsors1 location